Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Interventional × dalpiciclib × Clear all

Phase

Status

Recruiting 17 Unknown 11 Not yet recruiting 11 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Educational Status 6 Interviews as Topic 5 Fluorodeoxyglucose F18 5 Cisplatin 5 Standard of Care 4 Dexamethasone 4 camrelizumab 3 Radiotherapy 3 Nivolumab 3 Methods 3 Lenalidomide 3 Fluorouracil 3 Early Intervention, Educational 3 Cyclophosphamide 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 venetoclax 2 sintilimab 2 lenvatinib 2 fludarabine 2 durvalumab 2 Weights and Measures 2 Transcutaneous Electric Nerve Stimulation 2 Temozolomide 2 Specimen Handling 2 S 1 (combination) 2 Practice Guidelines as Topic 2 Patient Navigation 2 Paclitaxel 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡